Background: Rodent-borne viruses such as orthohantaviruses and arenaviruses cause considerable disease burden with regional and temporal differences in incidence and clinical awareness. Therefore, it is important to regularly evaluate laboratory diagnostic capabilities, e.g. by external quality assessments (EQA). Aim: We wished to evaluate the performance and diagnostic capability of European expert laboratories to detect orthohantaviruses and lymphocytic choriomeningitis virus (LCMV) and human antibody response towards orthohantaviruses. Methods: We conducted an EQA in 2021; molecular panels consisted of 12 samples, including different orthohantaviruses (Seoul, Dobrava-Belgrade (DOBV), Puumala (PUUV) and Hantaan orthohantavirus), LCMV and negative controls. Serological panels consisted of six human serum samples reactive to PUUV, DOBV or negative to orthohantaviruses. The EQA was sent to 25 laboratories in 20 countries. Results: The accuracy of molecular detection of orthohantaviruses varied (50‒67%, average 62%) among 16 participating laboratories, while LCMV samples were successfully detected in all 11 participating laboratories (91-100%, average 96%). The accuracy of serological diagnosis of acute and past orthohantavirus infections was on average 95% among 20 participating laboratories and 82% in 19 laboratories, respectively. A variety of methods was used, with predominance of in-house assays for molecular tests, and commercial assays for serological ones. Conclusion: Serology, the most common tool to diagnose acute orthohantavirus infections, had a high accuracy in this EQA. The molecular detection of orthohantaviruses needs improvement while LCMV detection (performed in fewer laboratories) had 95% accuracy. Further EQAs are recommended to be performed periodically to monitor improvements and challenges in the diagnostics of rodent–borne diseases.
Orthohantavirus tulaense (TULV) is a member of the orthohantavirus genus and distributed in Europe and Asia. To shed light on TULV epidemiology and evolution, we trapped wild rodents from eastern Turkiye and found 15 TULV positive rodents. Sequencing and phylogenetic analyses confirmed the presence of diverse TULV strains. Global phylogenetic characterization suggested 5 distinct TULV lineages. Global phylogeographic reconstruction estimated different rooting times for each three segments, a potential ancestor location in Eastern Black Sea region, and strongly supported phylogeographic structure with 11 clusters. Dispersal velocity of TULV was estimated to be much faster than some other orthohantaviruses. Eastern Black Sea seemed to have lineages evolving faster and genetically closer to proto-Tula virus. Host switching estimates suggested potential switching events from Microtus arvalis to M. obscurus to M. irani with host-dependent sub-clustering within geographic clusters and suggested substantial evidence for no clear virus jumps from M. arvalis to M. irani.
We report complete and partial genome sequences of rat hepatitis E virus (RHEV, Rocahepevirus ratti), from archived brown rats captured in Helsinki, Finland. Phylogenetic analysis confirmed the presence of the pathogenic RHEV genotype C1 in the Helsinki region. Finnish strains clustered together with strains from South Korea and Spain. However, the polytomous topology of phylogenetic trees and the large genetic distances between spatially distinct strains suggest that RHEV has remained inadequately sampled on a global scale. Further surveillance of rocahepeviruses is needed to assess their threat to public health and to understand their diversity and evolutionary patterns.
We report complete coding sequences of Orthohantavirus dobravaense (Dobrava virus) Igneada strains and phylogenetic characterization of all available complete coding sequences. Our analyses suggested separation of host-dependent lineages, followed by geographic clustering. Surveillance of orthohantaviruses using complete genomes would be useful for assessing public health threats from Dobrava virus.